The vaccine for covid -19 from Novavax and Astrazeneca will be introduced by serum institute and this is released that it will be priced less than Rs 250 per Dose in India. The serum Institute of India announced that it would offer upto 100 million doses priced at $3 for 92 middle and low income countries.
SII said that , the vaccine will be available in the first half fo 2021 just after it gains the approvals and qualifications from the world health organization.
Dr Balram Bhargava, Director General of Indian Council of Medical Research (ICMR),said , “India has demonstrated consistent capability in delivering low-cost and high-quality medical research, while also maintaining technical and scientific rigour. ICMR is deeply supportive of our cutting edge vaccine research and manufacturing prowess, of which SII is one prominent example. This partnership signifies yet another step in India’s efforts to bolster the fight against this global pandemic.”
The two agreements have been signed by SII for the supply of covid vaccine. One is with AstraZeneca-Oxford’s candidate and the other one is US based Novavax.